Actelion Pharmaceuticals Ltd

act-709725 - mechlorethamine

 

Study ID Status Type Title
AC-079A501 Ongoing Protocol Summary A PROspective, observational, US-based study assessing outcomes, adverse events, treatment patterns, and quality of life in patients diagnosed with mycosis fungoides cutaneous T-cell lymphoma and treated with Valchlor®